David A. Siegel Athenex, Inc. Transaction History

Two Sigma Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $2.33 Million - $3.22 Million	-627,937 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $238,680 - $862,875	58,500 Added 10.27%	627,937 $2.7 Million
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $4.93 Million - $6.24 Million	445,300 Added 358.72%	569,437 $6.3 Million
Q3 2020 Nov 16, 2020	SELL	$10.26 - $14.55 $578,664 - $820,620	-56,400 Reduced 31.24%	124,137 $1.5 Million
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $367,587 - $711,392	-51,700 Reduced 22.26%	180,537 $2.48 Million
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $683,487 - $1.9 Million	119,700 Added 106.37%	232,237 $1.8 Million
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $800,832 - $1.48 Million	83,420 Added 286.5%	112,537 $1.72 Million
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $354,062 - $611,457	29,117 New	29,117 $354,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.